Global Plasma Fractionation Market by Product (Albumin, Coagulation Factor Concentrates, Immunoglobulin), Application (Critical Care, Hemato-Oncology, Hematology), End-User - Cumulative Impact of High Inflation - Forecast 2023-2030- Product Image

Sale

Global Plasma Fractionation Market by Product (Albumin, Coagulation Factor Concentrates, Immunoglobulin), Application (Critical Care, Hemato-Oncology, Hematology), End-User - Cumulative Impact of High Inflation - Forecast 2023-2030

Report
243 Pages
May 2023
Region: Global
360iResearch™
ID: 5336507

UP TO €866EUR$895USD£748GBP OFF until Jun 30^th 2023

The Global Plasma Fractionation Market size was estimated at USD 32.46 billion in 2022, USD 35.84 billion in 2023, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10.54% to reach USD 72.40 billion by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Plasma Fractionation Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Plasma Fractionation Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Albumin, Coagulation Factor Concentrates, Immunoglobulin, and Protease Inhibitors. The Coagulation Factor Concentrates is further studied across Factor IX, Factor VIII, Factor XIII, Fibrinogen Concentrates, Prothrombin Complex Concentrate, and Von Willebrand Factor. The Immunoglobulin is further studied across Intravenous Immunoglobulin and Subcutaneous Immunoglobulin. The Protease Inhibitors is projected to witness significant market share during forecast period.
Based on Application, market is studied across Critical Care, Hemato-Oncology, Hematology, Neurology, Pulmonology, and Rheumatology. The Rheumatology is projected to witness significant market share during forecast period.
Based on End-User, market is studied across Academic & Research Institutes and Clinical Research Laboratories. The Clinical Research Laboratories is projected to witness significant market share during forecast period.
Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.72% in 2022, followed by Europe, Middle East & Africa.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Plasma Fractionation Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Plasma Fractionation Market, including ADMA Biologics Inc., Baxter International Inc., Bharat Serums and Vaccines Limited, Bio Products Laboratory Ltd., China Biologic Products Holdings, Inc., CRB Group, Inc., CSL Limited, Emergent BioSolutions Inc., Intas Pharmaceuticals, Japan Blood Products Organization, Sanquin Blood Supply Foundation, Shanghai RAAS Blood Products Co., Ltd., Shire Plc, Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd., Takeda Pharmaceutical Company Limited, and Virchow Biotech Pvt., Ltd.

The report provides insights on the following pointers:

Market Penetration: Provides comprehensive information on the market offered by the key players
Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets
Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation
Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

What is the market size and forecast of the Global Plasma Fractionation Market?
What are the inhibiting factors and impact of COVID-19 shaping the Global Plasma Fractionation Market during the forecast period?
Which are the products/segments/applications/areas to invest in over the forecast period in the Global Plasma Fractionation Market?
What is the competitive strategic window for opportunities in the Global Plasma Fractionation Market?
What are the technology trends and regulatory frameworks in the Global Plasma Fractionation Market?
What is the market share of the leading vendors in the Global Plasma Fractionation Market?
What modes and strategic moves are considered suitable for entering the Global Plasma Fractionation Market?

Frequently Asked Questions about the Global Plasma Fractionation Market

What is the estimated value of the Global Plasma Fractionation Market?

The Global Plasma Fractionation Market was estimated to be valued at $32.46 Billion in 2022.

What is the growth rate of the Global Plasma Fractionation Market?

The growth rate of the Global Plasma Fractionation Market is 10.5%, with an estimated value of $72.4 Billion by 2030.

What is the forecasted size of the Global Plasma Fractionation Market?

The Global Plasma Fractionation Market is estimated to be worth $72.4 Billion by 2030.

Who are the key companies in the Global Plasma Fractionation Market?

Key companies in the Global Plasma Fractionation Market include ADMA Biologics Inc., Baxter International Inc., Bharat Serums and Vaccines Limited, Bio Products Laboratory Ltd., China Biologic Products Holdings, Inc., CRB Group, Inc., CSL Limited, Emergent BioSolutions Inc., Intas Pharmaceuticals and Japan Blood Products Organization.

Report Attribute	Details
No. of Pages	243
Published	May 2023
Forecast Period	2022 - 2030
Estimated Market Value ( USD ) in 2022	$ 32.46 Billion
Forecasted Market Value ( USD ) by 2030	$ 72.4 Billion
Compound Annual Growth Rate	10.5%
Regions Covered	Global
No. of Companies Mentioned	16

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Plasma Fractionation Market, by Product, 2022 vs 2030
4.3. Plasma Fractionation Market, by Application, 2022 vs 2030
4.4. Plasma Fractionation Market, by End-User, 2022 vs 2030
4.5. Plasma Fractionation Market, by Region, 2022 vs 2030

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Improving access to plasma-based therapies and high use of immunoglobulins in various therapeutic areas
5.1.1.2. Government initiatives to increase plasma collection
5.1.1.3. Increasing number of blood collection facilities
5.1.2. Restraints
5.1.2.1. High cost and limited reimbursement and emergence of recombinant alternatives
5.1.3. Opportunities
5.1.3.1. Advancements in process development for improved formulations
5.1.3.2. Exponential utilization in new clinical trials
5.1.4. Challenges
5.1.4.1. Stringent government regulations on plasma fractionation
5.1.4.2. Challenges in continuously supplying safe products through effective removal or inactivation
5.2. Market Trends
5.3. Cumulative Impact of COVID-19
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework
5.9. Client Customization
5.9.1. Fractionation capacities and geographical expansions
5.9.2. Fractionator-owned plasma collection centers
5.9.3. New indications for plasma products

6. Plasma Fractionation Market, by Product

6.1. Introduction
6.2. Albumin
6.3. Coagulation Factor Concentrates
6.3.1. Factor IX
6.3.2. Factor VIII
6.3.3. Factor XIII
6.3.4. Fibrinogen Concentrates
6.3.5. Prothrombin Complex Concentrate
6.3.6. Von Willebrand Factor
6.4. Immunoglobulin
6.4.1. Intravenous Immunoglobulin
6.4.2. Subcutaneous Immunoglobulin
6.5. Protease Inhibitors

7. Plasma Fractionation Market, by Application

7.1. Introduction
7.2. Critical Care
7.3. Hemato-Oncology
7.4. Hematology
7.5. Neurology
7.6. Pulmonology
7.7. Rheumatology

8. Plasma Fractionation Market, by End-User

8.1. Introduction
8.2. Academic & Research Institutes
8.3. Clinical Research Laboratories

9. Americas Plasma Fractionation Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Plasma Fractionation Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Plasma Fractionation Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario

13. Company Usability Profiles

13.1. ADMA Biologics Inc.
13.2. Baxter International Inc.
13.3. Bharat Serums and Vaccines Limited
13.4. Bio Products Laboratory Ltd.
13.5. China Biologic Products Holdings, Inc.
13.6. CRB Group, Inc.
13.7. CSL Limited
13.8. Emergent BioSolutions Inc.
13.9. Intas Pharmaceuticals
13.10. Japan Blood Products Organization
13.11. Sanquin Blood Supply Foundation
13.12. Shanghai RAAS Blood Products Co., Ltd.
13.13. Shire Plc
13.14. Sichuan Yuanda Shuyang Pharmaceutical Co. Ltd.
13.15. Takeda Pharmaceutical Company Limited
13.16. Virchow Biotech Pvt., Ltd

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. PLASMA FRACTIONATION MARKET RESEARCH PROCESS
FIGURE 2. PLASMA FRACTIONATION MARKET SIZE, 2022 VS 2030
FIGURE 3. PLASMA FRACTIONATION MARKET SIZE, 2018-2030 (USD BILLION)
FIGURE 4. PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
FIGURE 5. PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2022 VS 2030 (%)
FIGURE 6. PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
FIGURE 7. PLASMA FRACTIONATION MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 8. PLASMA FRACTIONATION MARKET DYNAMICS
FIGURE 9. PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 10. PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 11. PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 12. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 13. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 14. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 15. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD BILLION)
FIGURE 16. PLASMA FRACTIONATION MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 17. PLASMA FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2022

List of Tables

TABLE 1. PLASMA FRACTIONATION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. PLASMA FRACTIONATION MARKET SIZE, 2018-2030 (USD BILLION)
TABLE 4. PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 5. PLASMA FRACTIONATION MARKET SIZE, BY ALBUMIN, BY REGION, 2018-2030 (USD BILLION)
TABLE 6. PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 7. PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, BY REGION, 2018-2030 (USD BILLION)
TABLE 8. PLASMA FRACTIONATION MARKET SIZE, BY FACTOR IX, BY REGION, 2018-2030 (USD BILLION)
TABLE 9. PLASMA FRACTIONATION MARKET SIZE, BY FACTOR VIII, BY REGION, 2018-2030 (USD BILLION)
TABLE 10. PLASMA FRACTIONATION MARKET SIZE, BY FACTOR XIII, BY REGION, 2018-2030 (USD BILLION)
TABLE 11. PLASMA FRACTIONATION MARKET SIZE, BY FIBRINOGEN CONCENTRATES, BY REGION, 2018-2030 (USD BILLION)
TABLE 12. PLASMA FRACTIONATION MARKET SIZE, BY PROTHROMBIN COMPLEX CONCENTRATE, BY REGION, 2018-2030 (USD BILLION)
TABLE 13. PLASMA FRACTIONATION MARKET SIZE, BY VON WILLEBRAND FACTOR, BY REGION, 2018-2030 (USD BILLION)
TABLE 14. PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 15. PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, BY REGION, 2018-2030 (USD BILLION)
TABLE 16. PLASMA FRACTIONATION MARKET SIZE, BY INTRAVENOUS IMMUNOGLOBULIN , BY REGION, 2018-2030 (USD BILLION)
TABLE 17. PLASMA FRACTIONATION MARKET SIZE, BY SUBCUTANEOUS IMMUNOGLOBULIN , BY REGION, 2018-2030 (USD BILLION)
TABLE 18. PLASMA FRACTIONATION MARKET SIZE, BY PROTEASE INHIBITORS, BY REGION, 2018-2030 (USD BILLION)
TABLE 19. PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 20. PLASMA FRACTIONATION MARKET SIZE, BY CRITICAL CARE, BY REGION, 2018-2030 (USD BILLION)
TABLE 21. PLASMA FRACTIONATION MARKET SIZE, BY HEMATO-ONCOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 22. PLASMA FRACTIONATION MARKET SIZE, BY HEMATOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 23. PLASMA FRACTIONATION MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 24. PLASMA FRACTIONATION MARKET SIZE, BY PULMONOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 25. PLASMA FRACTIONATION MARKET SIZE, BY RHEUMATOLOGY, BY REGION, 2018-2030 (USD BILLION)
TABLE 26. PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 27. PLASMA FRACTIONATION MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD BILLION)
TABLE 28. PLASMA FRACTIONATION MARKET SIZE, BY CLINICAL RESEARCH LABORATORIES, BY REGION, 2018-2030 (USD BILLION)
TABLE 29. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 30. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 31. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 32. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 33. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 34. AMERICAS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 35. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 36. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 37. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 38. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 39. ARGENTINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 40. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 41. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 42. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 43. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 44. BRAZIL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 45. CANADA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 46. CANADA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 47. CANADA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 48. CANADA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 49. CANADA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 50. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 51. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 52. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 53. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 54. MEXICO PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 55. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY STATE, 2018-2030 (USD BILLION)
TABLE 56. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 57. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 58. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 59. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 60. UNITED STATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 61. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 62. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 63. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 64. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 65. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 66. ASIA-PACIFIC PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 67. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 68. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 69. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 70. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 71. AUSTRALIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 72. CHINA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 73. CHINA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 74. CHINA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 75. CHINA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 76. CHINA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 77. INDIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 78. INDIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 79. INDIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 80. INDIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 81. INDIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 82. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 83. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 84. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 85. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 86. INDONESIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 87. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 88. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 89. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 90. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 91. JAPAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 92. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 93. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 94. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 95. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 96. MALAYSIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 97. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 98. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 99. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 100. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 101. PHILIPPINES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 102. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 103. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 104. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 105. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 106. SINGAPORE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 107. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 108. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 109. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 110. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 111. SOUTH KOREA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 112. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 113. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 114. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 115. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 116. TAIWAN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 117. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 118. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 119. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 120. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 121. THAILAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 122. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 123. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 124. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 125. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 126. VIETNAM PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD BILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 131. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 132. EUROPE, MIDDLE EAST & AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 133. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 134. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 135. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 136. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 137. DENMARK PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 138. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 139. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 140. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 141. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 142. EGYPT PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 143. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 144. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 145. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 146. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 147. FINLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 148. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 149. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 150. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 151. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 152. FRANCE PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 153. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 154. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 155. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 156. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 157. GERMANY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 158. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 159. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 160. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 161. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 162. ISRAEL PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 163. ITALY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 164. ITALY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 165. ITALY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 166. ITALY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 167. ITALY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 168. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 169. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 170. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 171. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 172. NETHERLANDS PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 173. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 174. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 175. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 176. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 177. NIGERIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 178. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 179. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 180. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 181. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 182. NORWAY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 183. POLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 184. POLAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 185. POLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 186. POLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 187. POLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 188. QATAR PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 189. QATAR PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 190. QATAR PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 191. QATAR PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 192. QATAR PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 193. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 194. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 195. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 196. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 197. RUSSIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 198. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 199. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 200. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 201. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 202. SAUDI ARABIA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 203. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 204. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 205. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 206. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 207. SOUTH AFRICA PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 208. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 209. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 210. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 211. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 212. SPAIN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 213. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 214. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 215. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 216. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 217. SWEDEN PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 218. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 219. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 220. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 221. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 222. SWITZERLAND PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 223. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 224. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 225. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 226. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 227. TURKEY PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 228. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 229. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 230. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 231. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 232. UNITED ARAB EMIRATES PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 233. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY PRODUCT, 2018-2030 (USD BILLION)
TABLE 234. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY COAGULATION FACTOR CONCENTRATES, 2018-2030 (USD BILLION)
TABLE 235. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY IMMUNOGLOBULIN, 2018-2030 (USD BILLION)
TABLE 236. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD BILLION)
TABLE 237. UNITED KINGDOM PLASMA FRACTIONATION MARKET SIZE, BY END-USER, 2018-2030 (USD BILLION)
TABLE 238. PLASMA FRACTIONATION MARKET, FPNV POSITIONING MATRIX, SCORES, 2022
TABLE 239. PLASMA FRACTIONATION MARKET, FPNV POSITIONING MATRIX, BUSINESS STRATEGY, 2022
TABLE 240. PLASMA FRACTIONATION MARKET, FPNV POSITIONING MATRIX, PRODUCT SATISFACTION, 2022
TABLE 241. PLASMA FRACTIONATION MARKET RANKING, BY KEY PLAYER, 2022
TABLE 242. PLASMA FRACTIONATION MARKET SHARE, BY KEY PLAYER, 2022
TABLE 243. PLASMA FRACTIONATION MARKET LICENSE & PRICING